Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Johan Wernlund"'
Autor:
Michael Bergqvist, Daniel Brattström, Kristina Lamberg, Patrik Hesselius, Johan Wernlund, Anders Larsson, Gunnar Wagenius
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 5, Iss 4, Pp 283-287 (2003)
BACKGROUND: During recent years, a correlation between the presence of antibodies in sera against p53 and survival has been reported. The aim of the present study was to analyze anti-p53 antibodies in sera from patients with non small cell lung cance
Externí odkaz:
https://doaj.org/article/09ccbf17ee7f4e3d9ca4445b77353d7f
Autor:
P Hesselius, Michael Bergqvist, Anders Larsson, Johan Wernlund, Gunnar Wagenius, Daniel Brattström, Kristina Lamberg
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 5, Iss 4, Pp 283-287 (2003)
BACKGROUND: During recent years, a correlation between the presence of antibodies in sera against p53 and survival has been reported. The aim of the present study was to analyze anti-p53 antibodies in sera from patients with non small cell lung cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcae1699bb217b745b3d5bf785c3b2e0
https://doi.org/10.1016/s1476-5586(03)80021-0
https://doi.org/10.1016/s1476-5586(03)80021-0
Autor:
Johan Wernlund, Hans Tydén, Göran Hedenstierna, Vitas Zemgulis, Stefan Thelin, Lennart Magnusson, Arne Tenling
Publikováno v:
Anesthesiology. 88:134-142
Background Respiratory failure secondary to cardiopulmonary bypass (CPB) remains a major complication after cardiac surgery. The authors previously found that the increase in intrapulmonary shunt was well correlated with the amount of atelectasis. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b4f82945eb703bbb976e0604127d56f
https://doi.org/10.1097/00000542-199801000-00021
https://doi.org/10.1097/00000542-199801000-00021
Publikováno v:
Anticancer research. 23(1B)
Mesothelioma is a rare disease with poor prognosis. Monitoring the effect of treatment is a problem and a serum marker might be of use for this purpose. We have studied three serum markers TPA, Hyaluronan and CA 125 in a limited material (11 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e15c50085c51f1f443f29e66641e4198
https://pubmed.ncbi.nlm.nih.gov/12680141
https://pubmed.ncbi.nlm.nih.gov/12680141
Autor:
Gunnar Wagenius, P Hesselius, Michael Bergqvist, Anders Larsson, Ola Brodin, Kristina Lamberg, Daniel Brattström, Johan Wernlund
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 37(1)
We have analysed the predictive and prognostic information in preoperatively collected serum levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients clinically evaluated as operable non-small cell lun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5a9df1a021e325325029f02edfdac01
https://pubmed.ncbi.nlm.nih.gov/12057868
https://pubmed.ncbi.nlm.nih.gov/12057868
Publikováno v:
Lung Cancer. 41:S217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23e7e2581628337e4fc675d06301729d
https://doi.org/10.1016/s0169-5002(03)92469-x
https://doi.org/10.1016/s0169-5002(03)92469-x